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File S1. Lists of identified E2 and ER-regulated genes. Figure S3 . Validation of E2-and ER-dependent transcriptomes. To confirm the transcriptional regulations determined from the array-based experiments, we performed independent RT-qPCR assays using mRNAs prepared from livers of ERWT and ERKO animals, treated or not with E2 (n>6 for each conditions). Observed fold changes (FC) in these experiments are compared with those expected from arrays data in a heatmap (A) or a graph (B) of results. The number and % of confirmed regulations are given within (A) and the correlation coefficient in (B). The § symbol within the heatmap signals significant variations of Upp2 and Etnk2 genes, but below the 1.5 fold change treshold; and are thus not included in the set of confirmed regulations. (C) Examples of confirmed transcriptional regulations. Results shown are the mean ± SD expression values normalized to those of a control gene (Hprt1) and expressed as fold changes vs. the ERWT placebo (P) condition. Mann-Whitney t-test were performed to determine whether the fold-changes were significant towards the ERWT P condition. In order to compare the different sets of ChIP-seq data, we first used different statistic p-value thresholds for determining the ER BSs (B) and determined pairwise overlaps at these different thresholds (C). We used the inflexion points of these curves to determine the optimal threshold for each datasest: a p-value of 10-5 for all ER cistromes except for the uterus data which was used with a 10-8 p-value. (D and E) Venn diagrams illustrating the overlap of the ER liver cistrome determined here with those from identified elsewhere in liver (D), and of these liver ER BSs with aorta and uterus ER cistromes (E). (F) Conservation plots of the different set of ERBSs used in this study against the mm9(vertebrate) database of the cistrome platform (http://cistrome.org/ap/root). Figure S5 . ER ChIP-qPCR data. (A to E) Anti-ER ChIP experiments were performed on 4 liver chromatin samples originating from independent ERWT placebo (P) or E2-treated mice or E2-treated ERKO individuals, using mixes of antibodies directed against either the C-terminal (black bars) or N-terminal (grey bars) domains of ER. Additionnally, in the case of the anti-ER C-terminal ChIP-qPCR, a fraction of the pooled sample that was subjected to HTS was evaluated in parallel. A control ChIP using non-specific antibody was performed in parallel as a control reference (white bars). Shown within the histograms are mean ± SD values obtained on the tested genomic regions (n=5 or n=4) normalized to those obtained on a non-specific control (promoter of the Rplp0 gene). Mann-Whitney t-test were performed to determine whether the enrichments obtained using C-or N-terminal antibodies were significant as compared to the control ChIP. Calculated p-values are indicated within the charts as follows: *< 0.05; **<0.01 ; ***<0.001. Fold Enrichment
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Fold Enrichment Table S4 ). Mann-Whitney t-test were performed to determine whether the enrichments obtained were significantly different in ERKO as compared to ERWT mice. Calculated p-values are indicated within the charts as follows: *< 0.05; **<0.01. 
Foxa2
Figure S12. Foxa2 expression in wild-type and ERKO mouse livers. (A) The expression of FoxA2 mRNA was evaluated by RT-qPCR in Placebo-treated (P) livers of ovariectomized ERWT and ERKO mice. Results shown are the mean ± SD expression values normalized to those of a control gene (Hprt1) and expressed as fold changes vs. the ERWT condition. (B and C) Representative results of Western blot (WB) assays following the expression of Foxa2 (B) and ER (C) proteins in 70 g of total protein extracts prepared from the livers of four different ERWT or ERKO mice. We assayed in parallel the GAPDH relative protein levels, as loading control. FoxA2 position is indicated by an arrow (apparent size of 52-55 kDa), and the numbers on top of the gels refer to individuals. WM stands for weight marker. 
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